Elucida Oncology
Executives
View the org chart displaying its 16 main executives
Most searched biographies at Elucida Oncology
- Geno Germano, President, Chief Executive Officer and Director
- Ulrich Wiesner, Director
- Robert Essner, Chairman of the Board
Popular executive movements at Elucida Oncology
- Ian Somaiya, Chief Financial Officer and Chief Business Officer, has left the company (posted on August 25 2023).
- Ramzi Benamar will join the company as Chief Financial Officer on Sep. 1, 2023 (posted on August 25 2023).
Create your alert
to follow the executive moves at Elucida Oncology.
Biotechnology
Elucida Oncology has 2,288 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).
Popular M&A news in Biotechnology
- Attovia Therapeutics has just announced a $150 Million fundraising (posted on May 14 2024).
- Bruker has announced the acquisition of NanoString Technologies (posted on May 13 2024).
- Aardvark Therapeutics has just announced a $85 Million fundraising (posted on May 12 2024).
Popular contacts in Biotechnology
News
Press releases by Elucida Oncology
- Elucida Oncology to Present at the 42nd Annual J.P. Morgan Healthcare Conference :: Elucida Oncology, Inc.
- Elucida Oncology Presents Encouraging Clinical Data from Phase 1/2 Study of ELU001 in Solid Tumors Overexpressing Folate Receptor Alpha at ESMO Congress 2023 :: Elucida Oncology, Inc.
- Elucida Oncology Announces Abstract Accepted for Poster Presentation at ESMO Congress 2023 :: Elucida Oncology, Inc.
- Elucida Oncology Appoints Ramzi Benamar as Chief Financial Officer :: Elucida Oncology, Inc.
- Elucida Oncology Announces First Patient Dosed with ELU001 in Expansion Cohort of its Phase 1/2 Clinical Trial :: Elucida Oncology, Inc.
- Elucida Oncology Announces Positive Early Phase 1 Safety Data Along with Preclinical Data for the Treatment of Brain Metastases for ELU001, an Anti-Folate Receptor Alpha C’Dot Drug Conjugate :: Elucida Oncology, Inc.
- Elucida Oncology to Present New Clinical and Preclinical Data at the 2023 AACR Annual Meeting :: Elucida Oncology, Inc.
- Elucida Oncology to Present at the 41st Annual J.P. Morgan Healthcare Conference :: Elucida Oncology, Inc.
- Elucida Oncology to Present at the Piper Sandler 34th Annual Healthcare Conference :: Elucida Oncology, Inc.
- Elucida Oncology to Present at Two Upcoming Conferences :: Elucida Oncology, Inc.
- View more press releases Close
Social media about Elucida Oncology
- Elucida Oncology on Wikipedia, Google News & Yahoo Finance
- Elucida Oncology on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Geno Germano 
Call Elucida Oncology at +1 646...
